|
|
||||||||
1 School of Veterinary Science, The University of Queensland, Brisbane, QLD 4072, Australia
2 Medical Faculty of the Christian University of Indonesia (FK-UKI), Cawang Atas, Jakarta, Indonesia
3 Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology and Immunology, School of Medicine, Creighton University, Omaha, Nebraska, USA
4 Microbiology and Infectious Diseases, Women's and Children's Hospital, North Adelaide, SA 5006, Australia
Correspondence
Darren J. Trott
d.trott{at}uq.edu.au
Received 14 August 2006
Accepted 27 October 2006
140 kb) that also conferred resistance to chloramphenicol, gentamicin, spectinomycin, tetracycline, trimethoprim and sulfonamides. In all plasmid-mediated extended-spectrum ß-lactamase (ESBL)-producing isolates including transconjugants, blaSHV-12 was shown to reside in a
6.5 kb plasmid fragment. The remaining isolate that was not an ESBL producer possessed an AmpC ß-lactamase gene (blaCMY-2) on a
93 kb transmissible plasmid. This plasmid did not contain any other antimicrobial resistance genes. Additional plasmid-mediated ß-lactamases identified in some isolates included blaTEM and blaOXA-10. This is the first report of canine Enterobacter isolates containing transmissible plasmid-mediated blaSHV-12 and blaCMY-2 resistance genes. Therefore, Enterobacter isolated from opportunistic infections in dogs may be an important reservoir of plasmid-mediated resistance genes, which could potentially be spread to other members of the Enterobacteriaceae.
Abbreviations: ESBL, extended-spectrum ß-lactamase; MDR, multidrug-resistant; MDREC, MDR Escherichia coli.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |